Alamar Biosciences Reports Q3 2026 Results, Raises Revenue Guidance
Alamar Biosciences reported results for the quarter ended September 30, 2026, and raised its 2026 revenue guidance.
Story updates
09:08:53 PM UTC
SquawkNews
Q3 2026 revenue rose 68% year over year to $33.5M, from $19.9M. Alamar raised its 2026 revenue outlook to $121M—$123M from $116M—$120M, representing 64% growth at the range midpoint versus 2025.Material DetailsContext by AI AnalystThis is a mid-cycle growth update, with strong year-over-year revenu…
09:14:37 PM UTC
SquawkNews
*-- Earnings Flash (ALMR) Alamar Biosciences, Inc. Reports Q3 Revenue $33.5M, vs.
FREMONT, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. NASDAQ:ALMR, a leader in precision proteomics dedicated to enabling the earliest detection of disease, today reported financial results for the quarter ended September 30, 2026.Recent Highlights“Our third quarter results re…